WASHINGTON–(BUSINESS WIRE)–#congress–Today, Council for Citizens Against Government Waste (CCAGW) President Tom Schatz issued the following statement in response to the announcement of two proposed Center for Medicare and Medicaid Innovation (CMMI) models, “GLOBE” and “GUARD,” that seek to advance so-called ‘most favored nation’ (MFN) drug price controls: “CCAGW is disappointed to see the administration push … [Read more…]
TORONTO–(BUSINESS WIRE)–Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN), a clinical-stage breakthrough pharmaceutical company committed to revolutionizing mental healthcare by developing innovative next-generation treatment options, today announced that it will voluntarily transfer its U.S. stock exchange listing to the Nasdaq Global Market (“Nasdaq”) from the NYSE American LLC (“NYSE American”). The Company expects that its common shares … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “ENT Disorder Treatment Market – Global Forecast 2025-2032” report has been added to ResearchAndMarkets.com’s offering. The ENT disorder treatment market is experiencing rapid transformation as organizations adopt new medical technologies and evolving care models to address complex clinical and operational challenges. Senior decision-makers are seeking strategies that enable both enhanced patient outcomes and … [Read more…]
Urges Board to Allow Shareholders to Have Their Final Say on This Ill-Conceived Transaction NEW YORK–(BUSINESS WIRE)–Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”), which together own 30.2% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), today responded to the fourth postponement of STAAR’s Special Meeting of … [Read more…]
CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced the U.S. launch of the next generation LifeVest® wearable cardioverter defibrillator (WCD). This marks the fifth FDA-approved LifeVest WCD, which works seamlessly with the recently launched next generation LifeVest WCD garment, the most comfortable LifeVest WCD ever.1 Backed by … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “MBA Strategic Thinking for Pharma and Biopharma Professionals Training Course (Feb 23rd – Feb 24th, 2026)” training has been added to ResearchAndMarkets.com’s offering. Working in the highly competitive pharmaceutical industry, with ever-increasing change and pressure, is probably one of the most challenging managerial roles of any industry today. This MBA strategic thinking workshop … [Read more…]
MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announced today that it will participate in the 44th Annual J.P. Morgan Healthcare Conference, San Francisco, USA, to be held on January … [Read more…]
TOKYO–(BUSINESS WIRE)–Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo; President & CEO: Toshiaki Nagasato) today announced that it has entered into a partnership agreement with MBC BioLabs which is a private organization supporting the development of biotech startup companies in California’s San Francisco Bay Area. MBC BioLabs provides fully equipped research facilities and a supportive … [Read more…]
BRISBANE, Calif.–(BUSINESS WIRE)–CareDx, Inc. (Nasdaq: CDNA) today provided notice of proposed settlement of derivative actions and settlement hearing. UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA JEFFREY EDELMAN, JAYSEN Case No. 3:25-cv-02036-TLT STEVENSON, and CHRISTIAN JACOBSEN, (Shareholder Derivative Action) Derivatively on Behalf of CareDx, Inc., SUMMARY NOTICE OF PENDENCY AND PROPOSED SETTLEMENT OF … [Read more…]
SUNNYVALE, Calif.–(BUSINESS WIRE)–EBR Systems, Inc., developer of the world’s only left ventricular wireless cardiac pacing device for heart failure, today announced that management will be presenting at the J.P. Morgan 2026 Healthcare Conference on Thursday, January 15, 2026, at the Westin St. Francis in San Francisco, CA. About EBR Systems EBR Systems is a cardiac … [Read more…]
